Skip to main content
OpenTrials
Completed

NCT Number: NCT04336761

Prevalence of Covid-19 in Children Admitted to Paediatric Emergency Departments During the Pandemic Period in France

Arriving in December 2019, Coronavirus COVID-19 infection is causing a global pandemic with high morbidity and mortality among adults and especially seniors. The child appears little or no affected by this infection. It is estimated that the child could be asymptomatic or pauci-symptomatic carrier and thus be vector of the disease. For this reason, measures have been taken to close schools and contain populations in a large number of countries, including France. However, there are no data on the prevalence of COVID-19 in children.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Coronavirus COVID Coronaviridae Infections Coronavirus Infections Infection Viral Infections Nidovirales Infections RNA Virus Infections Virus Diseases

Age range

Up to 18 year

Sex eligibility

All sexes

Study type

Observational

Primary location

CH Louis MOURIER, Colombes, France

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 1st Line Consultation in Pediatric Emergencies
  • All reasons for consultation during working hours
  • Informed and written consent of a parent holder (only 1 authorized companion) and a child of understanding age

Exclusion criteria

  • Refusal of participation by parents/child of decision age
  • No membership of a social security scheme (beneficiary or entitled)
  • No understanding of French

Treatment and study plan

Nasopharyngeal swab

Diagnostic Test

Data collection and nasopharyngeal swab

Primary outcomes

  1. Prevalence of positivity of COVID-19 virus measured by rt-PCR

    Time frame: At 28 days

Secondary outcomes

  1. Prevalence of positivity of COVID-19 virus measured by rt-PCR in the following subpopulations of emergency patients

    Time frame: at the end an average 28 days

    children admitted to pediatric emergencies for respiratory signs

    • Children hospitalized as a result of travelling to pediatric emergency departments for respiratory signs
    • Respiratory asymptomatic children admitted to pediatric emergencies

  2. Respiratory signs of children tested within 28 day

    Time frame: through study completion, an average 28 days

  3. Percentage of children hospitalized tested within 28 day

    Time frame: through study completion, an average 28 days

  4. Contact frequency

    Time frame: At inclusion

    the degree of relationship with these contacts and the time spent in contact with them within 24 hours before emergency

  5. Prevalence of positivity of other respiratory viruses measured by rt-PCR

    Time frame: at 28 days

Sponsors and collaborators

Lead sponsor

University Hospital, Lille

Other

Registry information

Acronym: INCOVPED

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
Apr 7, 2020
Registry last updated
Mar 11, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.